Kaliumchloride B. Braun Melsungen

Potassium chloride, the active ingredient in Kaliumchloride B. Braun Melsungen, is an electrolyte (potassium supplement) presented as a sterile solution for injection for intravenous use. It is employed to correct hypokalemia and to provide potassium replacement therapy in patients who require electrolyte replenishment, such as those with cardiac arrhythmias, renal losses, or postoperative fluid shifts, and to maintain normal cellular function across muscle and nerve tissues.

GNH USA supplies Kaliumchloride B. Braun Melsungen as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Kaliumchloride B. Braun Melsungen, a potassium chloride solution, restores potassium via the electrolyte replacement pathway. - Hypokalemia: restores serum potassium to normal levels, reducing risk of cardiac and neuromuscular complications. - Diuretic‑induced potassium loss: replenishes potassium lost during loop or thiazide diuretic therapy. - Post‑operative fluid shifts: corrects potassium deficits that occur after major surgery. - Cardiac arrhythmias related to low potassium: helps stabilize cardiac membrane potential and prevent arrhythmic events.

Adverse reactions to intravenous potassium chloride may vary in frequency and severity.

Common Side Effects: - Injection site pain or irritation - Mild nausea or vomiting - Transient flushing or warmth sensation - Mild headache

Serious or Rare Side Effects: - Hyperkalemia leading to cardiac arrhythmia - Severe vein thrombophlebitis - Anaphylactic or severe allergic reaction - Cardiac arrest due to rapid infusion

When using Kaliumchloride B. Braun Melsungen, clinicians should observe several safety measures. - Monitor serum potassium: check levels before and during infusion to avoid overcorrection. - Infuse slowly: administer over recommended time to reduce risk of cardiac events. - Contraindicated in hyperkalemia: do not use when serum potassium is already elevated. - Caution in renal impairment: adjust dose and monitor closely in patients with reduced kidney function. - Avoid concurrent use with potassium‑sparing diuretics unless closely supervised. - Store below 25°C: keep in original container, protect from light and moisture.

Potassium chloride can interact with several medications, altering potassium balance or cardiac risk.

Major Interactions (Avoid): - ACE inhibitors or ARBs: may cause additive hyperkalemia. - Potassium‑sparing diuretics (e.g., spironolactone): increase risk of dangerous potassium elevation. - NSAIDs: can reduce renal potassium excretion, enhancing hyperkalemia risk.

Moderate Interactions (Monitor Closely): - Digoxin: elevated potassium can potentiate digoxin toxicity. - Beta‑blockers: combined effect on cardiac conduction may require monitoring. - Trimethoprim‑sulfamethoxazole: may raise serum potassium levels.